Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The 36% coefficient of variation for glucose proposed for separating stable and labile diabetes is clinically relevant: A continuous glucose monitoring-based study in a large population of type 1 diabetes patients.
Marchand L, Reffet S, Vouillarmet J, Cugnet-Anceau C, Disse E, Thivolet C. Marchand L, et al. Among authors: thivolet c. Diabetes Metab. 2019 Dec;45(6):598-600. doi: 10.1016/j.diabet.2018.05.009. Epub 2018 Jun 6. Diabetes Metab. 2019. PMID: 29910090 No abstract available.
Telemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?
Franc S, Borot S, Ronsin O, Quesada JL, Dardari D, Fagour C, Renard E, Leguerrier AM, Vigeral C, Moreau F, Winiszewski P, Vambergue A, Mosnier-Pudar H, Kessler L, Reffet S, Guerci B, Millot L, Halimi S, Thivolet C, Benhamou PY, Penfornis A, Charpentier G, Hanaire H. Franc S, et al. Among authors: thivolet c. Diabetes Metab. 2014 Feb;40(1):61-66. doi: 10.1016/j.diabet.2013.09.001. Epub 2013 Oct 16. Diabetes Metab. 2014. PMID: 24139705
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study.
Riveline JP, Vergés B, Detournay B, Picard S, Benhamou PY, Bismuth E, Bordier L, Jeandidier N, Joubert M, Roussel R, Sola-Gazagnes A, Bonnefond A, Clavel S, Velayoudom FL, Beltrand J, Hanaire H, Fontaine P, Thivolet C, Servy H, Tubiana S, Lion S, Gautier JF, Larger E, Vicaut E, Sablone L, Fagherazzi G, Cosson E. Riveline JP, et al. Among authors: thivolet c. Diabetes Metab. 2022 May;48(3):101306. doi: 10.1016/j.diabet.2021.101306. Epub 2021 Nov 21. Diabetes Metab. 2022. PMID: 34813929
213 results